会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • Monomers and Polymers with Covalently - Attached Active Ingredients
    • 具有共价连接活性成分的单体和聚合物
    • US20090208553A1
    • 2009-08-20
    • US12369125
    • 2009-02-11
    • Lisa Kay KempNIcholas Lee Hammond
    • Lisa Kay KempNIcholas Lee Hammond
    • A61L27/54C08L53/00A61L29/16A61L31/16
    • A61K31/74A61L27/34A61L29/085A61L31/10C08L53/02
    • Methods to form an active agent modified monomer comprising a ring opening cyclic monomer linked to an active agent via a degradable covalent linkage. Methods to form a polymer or copolymer comprising an active agent modified monomer. Methods to form an active agent modified monomer comprising combining a ring opening cyclic monomer with a first functional group (X) and an active agent with a second functional group (Y) to form an active agent modified monomer, wherein the first (X) and second (Y) functional groups are complementary functional groups that form a degradable linkage. The active agent modified monomer can also comprise a non-degradable linkage. The method can form a ring opening cyclic monomer that includes a cyclic carbonate, cyclic epoxide, lactam, lactone, lactide anhydride, cyclic carbamate, cyclic phosphoester, or siloxane. Apparatus that includes a medical device that comprises a polymer or copolymer that comprises an active agent modified monomer.
    • 形成活性剂改性单体的方法,所述单体包含通过可降解共价键与活性剂连接的开环环状单体。 形成包含活性剂改性单体的聚合物或共聚物的方法。 形成活性剂改性单体的方法,包括将开环环状单体与第一官能团(X)和活性剂与第二官能团(Y)组合以形成活性剂改性单体,其中第一(X)和 第二(Y)官能团是形成可降解键的互补官能团。 活性剂改性单体还可以包含不可降解的键。 该方法可以形成环状环状单体,其包括环状碳酸酯,环状环氧化物,内酰胺,内酯,丙交酯酐,环状氨基甲酸酯,环状磷酸酯或硅氧烷。 包括包含聚合物或共聚物的医疗装置的装置,其包含活性剂改性单体。